Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 9, Issue 1, 2008, Pages 10-16

  Collister, John P ^a   Nahey, David B ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Blood pressure; Dietary sodium; Losartan; Sodium and water balance

Indexed keywords

LOSARTAN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG RESPONSE; HIGH SODIUM INTAKE; HYPERTENSION; HYPOTHESIS; INTRAVENOUS CATHETER; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; TELEMETRY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; DRINKING; LOSARTAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SODIUM, DIETARY;

EID: 42249105057     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2008.008     Document Type: Article

References (38)

1. Collister JP, Osborn JW. Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats. Am J Physiol 1998;274:R357-66.
2. Collister JP, Hendel MD. Role of the subfornical organ in the chronic hypotensive response to losartan in normal rats. Hypertension 2003;41:576-82.
3. Collister JP, Hendel MD. The role of ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats. JRAAS 2003;4 176-9.doi:10.3317/jraas.2003.028.
4. Collister JP, Soucheray SL, Osborn JW. Chronic hypotensive effects of losartan are not dependent on the actions of angiotensin II at AT2 receptors. J Cardiovasc Pharmacol 2002;39:107-16.
5. Collister JP, Hornfeldt BJ, Osborn JW. Hypotensive response to losartan in normal rats. Role of Ang II and the area postrema. Hypertension 1996;27:598-606.
6. Collister JP, Osborn JW. Role of a responsive sympathetic nervous system in the chronic hypotensive effects of losartan in normal rats. J Cardiovasc Pharmacol 2005;46:147-54.
7. Wang DH, Du Y. Regulation of vascular type 1 angiotensin II receptor in hypertension and sodium loading: Role of angiotensin II. J Hypertens 1998;16:467-75.
8. Blair-West JR, Coghlan JP, Denton DA, Funder JW, Scoggins BA. Role of the renin-angiotensin system in control of aldosterone secretion. Adv Exp Med Biol 1972;17:167-81.
9. Marieb NJ, Mulrow PJ. Role of renin-angiotensin system in the regulation of aldosterone secretion in the rat. Endocrinology 1965;76 657-64.
10. McCaa RE, McCaa CS, Guyton AC. Role of angiotensin II and potassium in the long-term regulation of aldosterone secretion in intact conscious dogs. Circ Res 1975;36 (6 suppl 1):57-67.
11. McCaa RE. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure. Clin Exp Hypertens 1982; 4:1593-611.
12. Gandhi SK, Ryder DH, Brown NJ. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans. Hypertension 1996;28:961-6.
13. Davis WW, Burwell LR, Bartter FC. Inhibition of the effects of angiotensin II on adrenal steroid production by dietary sodium. Proc Natl Acad Sci USA 1969;63:718-23.
14. Cowley AW, McCaa RE. Acute and chronic dose-response relationships for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake. Circ Res 1976;39:788-97.
15. Schneider EG, Taylor RE Jr, Radke KJ, Davis PG. Effect of sodium concentration on aldosterone secretion by isolated perfused canine adrenal glands. Endocrinology 1984; 115:2195-204.
16. Schneider EG, Radke KJ, Ulderich DA, Taylor RE Jr. Effect of osmolality on aldosterone secretion. Endocrinology 1985;116:1621-6.
17. Hall JE, Guyton AC, Smith MJ Jr, Coleman TG. Chronic blockade of angiotensin II formation during sodium deprivation. Am J Physiol 1979;237:F424-32.
18. Carey RM, Wang ZQ, Siragy HM. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 2000;35:155-63.
19. Lopez JJ, Lorell BH, Ingelfinger JR et al. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 1994;267:H844-52.
20. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995;377:744-7.
21. Ichiki T, Labosky PA, Shiota C et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377:748-50.
22. Scheuer DA, Perrone MH. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol 1993 May;264:R917-23.
23. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 1996;27:760-5.
24. Stoll M, Steckelings UM, Paul M et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-7.
25. Nakajima M, Hutchinson HG, Fujinaga M et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995;92:10663-7.
26. Levy BI, Benessiano J, Henrion D et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996;98:418-25.
27. Gigante B, Piras O, De Paolis P et al. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats. J Hypertens 1998;16:2039-43.
28. Siragy HM, de Gasparo M, Carey RM. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 2000;35:1074-7.
29. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension 1997;30:535-41.
30. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides 1990;11:375-80.
31. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem 1989;264:16518-23.
32. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 1994;111:652-4.
33. Osei SY, Ahima RS, Minkes RK et al. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 1993;234(1):35-42.
34. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides 1993;14:883-91.
35. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994;23:439-49.
36. Campbell DJ, Kladis A, Valentijn AJ. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovasc Pharmacol 1995;26:233-40.
37. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998;31:699-705.
38. Iyer SN, Yamada K, Diz DI, Ferrario CM, Chappell MC. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J Cardiovasc Pharmacol 2000;36:109-17.